Sagimet Biosciences Statistics

Total Valuation

SGMT has a market cap or net worth of $170.10 million. The enterprise value is -$23.58 million.

Market Cap	170.10M
Enterprise Value	-23.58M

Important Dates

The last earnings date was Wednesday, May 15, 2024, before market open.

Earnings Date	May 15, 2024
Ex-Dividend Date	n/a

Share Statistics

SGMT has 31.91 million shares outstanding. The number of shares has increased by 15,585.37% in one year.

Shares Outstanding	31.91M
Shares Change (YoY)	+15,585.37%
Shares Change (QoQ)	+177.61%
Owned by Insiders (%)	14.28%
Owned by Institutions (%)	75.58%
Float	15.94M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	85.05
Forward PS	n/a
PB Ratio	0.90
P/FCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 43.12, with a Debt / Equity ratio of 0.00.

Current Ratio	43.12
Quick Ratio	n/a
Debt / Equity	0.00
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -61.90% and return on invested capital (ROIC) is -17.23%.

Return on Equity (ROE)	-61.90%
Return on Assets (ROA)	-26.90%
Return on Capital (ROIC)	-17.23%
Revenue Per Employee	$250,000
Profits Per Employee	-$3.49M
Employee Count	8
Asset Turnover	0.02
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

Beta (1Y)	n/a
52-Week Price Change	n/a
50-Day Moving Average	4.71
200-Day Moving Average	6.53
Relative Strength Index (RSI)	60.88
Average Volume (30 Days)	704,812

Short Selling Information

The latest short interest is 2.14 million, so 6.70% of the outstanding shares have been sold short.

Short Interest	2.14M
Short Previous Month	2.20M
Short % of Shares Out	6.70%
Short % of Float	13.42%
Short Ratio (days to cover)	5.07

Income Statement

In the last 12 months, SGMT had revenue of $2.00 million and -$27.92 million in losses. Loss per share was -$38.69.

Revenue	2.00M
Gross Profit	2.00M
Operating Income	-32.74M
Pretax Income	-27.92M
Net Income	-27.92M
EBITDA	-27.78M
EBIT	-27.92M
Loss Per Share	-$38.69

Full Income Statement

Balance Sheet

The company has $193.71 million in cash and $26,000 in debt, giving a net cash position of $193.68 million or $6.07 per share.

Cash & Cash Equivalents	193.71M
Total Debt	26,000
Net Cash	193.68M
Net Cash Per Share	$6.07
Equity / Book Value	190.02M
Book Value Per Share	5.95
Working Capital	189.98M

Full Balance Sheet

Cash Flow

Operating Cash Flow	-22.89M
Capital Expenditures	n/a
Free Cash Flow	-22.89M
FCF Per Share	-$0.79

Full Cash Flow Statement

Margins

Gross margin is 100.00%, with operating and profit margins of -1,637.15% and -1,395.90%.

Gross Margin	100.00%
Operating Margin	-1,637.15%
Pretax Margin	-1,395.90%
Profit Margin	-1,395.90%
EBITDA Margin	-1,388.85%
EBIT Margin	-1,395.90%
FCF Margin	-1,144.50%

Dividends & Yields

SGMT does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-15,585.37%
Shareholder Yield	-15,585.37%
Earnings Yield	-16.41%
FCF Yield	-13.46%

Analyst Forecast

The average price target for SGMT is $39.20, which is 627.96% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$39.20
Price Target Difference	627.96%
Analyst Consensus	Strong Buy
Analyst Count	6
Revenue Growth Forecast (5Y)	127.68%
EPS Growth Forecast (5Y)	6.74%

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

SGMT has an Altman Z-Score of 21.49 and a Piotroski F-Score of 2.

Altman Z-Score	21.49
Piotroski F-Score	2